June 12th, 2023The Chondrosarcoma Foundation in partnership with NORD® launched the Chondrosarcoma Patient Registry on March 1. The Chondrosarcoma Patient Registry creates a platform for patients around the world to strengthen their voices and share information...
Read ArticleJune 9th, 2023ABSTRACT Purpose: Patients with unresectable/metastatic chondrosarcoma have poor prognoses; conventional chondrosarcoma is associated with a median progression-free survival (PFS) of <4 months after first-line chemotherapy. No standard targeted...
Read ArticleJune 3rd, 2023By Elizabeth Goldstein-Rice Prepare. Communicate. Find Support. Read our Comprehensive Guide for the Newly Diagnosed There are numerous and important reasons why someone who has been diagnosed with sarcoma should be treated at a center where...
Read ArticleMay 20th, 2023ANN ARBOR, MI May 9, 2023 – SARC (Sarcoma Alliance for Research Through Collaboration) is proud to announce that it has launched a national, virtual multidisciplinary sarcoma tumor board. As the care of patients with cancer, particularly uncommon...
Read ArticleMay 19th, 2023Podcast: From Physician to Patient Dan Hurley, M.D. Dan Hurley, M.D. is an otolaryngologist (Ear, Nose, Throat) residing in Arizona. He was diagnosed with dediffereniated chondrosarcoma, a rare form of bone cancer. While he was preparing to receive...
Read ArticleMay 15th, 2023This coming Monday, May 22, we are going to do our first analysis of responses to the survey and take a first look at identifying trends and cause-effect relationships. Your responses to the survey questions are vital to this effort. We want to...
Read ArticleMay 12th, 2023During the past three years many CS Patients, caregivers, family members and friends have supported the Foundation through their donations and fund-raising activities. We received donations from family members in honor of their lost loved ones to...
Read ArticleMay 11th, 2023BOWIE, Maryland, May 12—The Chondrosarcoma (CS) Foundation will commemorate its third anniversary by continuing to educate the public about this rare bone cancer, advocate for patients fighting the disease and conduct a global natural history...
Read Article